bioAffinity Technologies
Biotech/Healthcare - San Antonio, TX, US
bioAffinity Technologies Employees
Andrew Wilson
Chief Executive Officer, President and Director at bioAffinity Technologies, Inc.
bioAffinity Technologies Senior Management
Andrew Wilson
Chief Executive Officer, President and Director at bioAffinity Technologies, Inc.
bioAffinity Technologies Details
Addressing a critical need to find cancer early and treat cancer specifically bioAffinity Technologies, Inc. develops tests and therapies to detect and treat cancer at the cellular level. Our first product, CyPath® Flow Cytometry for Lung Cancer (CyPath® Lung), has been licensed by Precision Pathology Services for continued development and commercial sale as a Laboratory Developed Test. CyPath® Lung has the potential to dramatically increase overall diagnostic accuracy leading to increased survival, fewer unnecessary invasive procedures and lower patient anxiety and medical costs.
bioAffinity Technologies Technologies
Email Providers
Outlook
Load Balancers
Apache
Fonts
Google Font API
Other
Mobile Friendly
CSS and JavaScript Libraries
Bootstrap Framework